Figure 1. Percentage of patients in the high-risk and very-high-risk groups receiving any form of lipid-lowering therapy (LLT) who have controlled and uncontrolled levels of low-density lipoprotein cholesterol (LDL-C).

Patients for whom data regarding LDL-C levels were not available were excluded. Controlled LDL-C levels were defined as <2.5 mmol/L in the high-risk group (including patients who are also included in the very-high-risk group), and <1.8 mmol/L in the very-high-risk group.